The mortality rate for dengue shock syndrome (DSS) in the PICU at Children's and Maternity Harapan Kita Hospital is still high (13.2%). OBJECTIVE: We evaluated performance of the Pediatric Logistic Organ Dysfunction (PELOD) score compared with the Pediatric Risk of Mortality III (PRISM III) for predicting mortality in our PICU. METHODS: A total of 42 patients (48% boys, 52% girls) admitted to the PICU from January to December 2006 were enrolled onto the study. Diagnosis of DSS was made according to 1997 World Health Organization criteria and confirmed with serologic-positive dengue blot taken on the fifth day of fever (93% secondary infection and 7% primary infection). PELOD and PRISM scores were evaluated on the first day. RESULTS: From 42 admissions, 1 was excluded for insufficient data. Median age of the children was 7 years. Death occurred in 11.9% of the patients with DSS. Analysis showed that the mean PELOD score was 7.2 (MannWhitney U test between survivors and nonsurvivors was significant at P ϭ .001) compared with the PRISM III (mean score was significant also at P ϭ .008). The receiver operating characteristic curves for the PELOD and PRISM III were 0.954 and 0.868, respectively. CONCLUSIONS: PELOD and PRISM III scores showed a good discrimination for predicting mortality in patients with DSS in our PICU. 
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RESULTS:
The most common S pneumoniae serotypes isolated were 6B and 19F (16.67% each) and 6A, 14, and 23F (15.27% each) . The overall rate of resistance (defined as the rate of intermediate resistance plus the rate of resistance) for penicillin was 65.38% (intermediate and resistant categories were 29.17% and 36.11%, respectively), for cefotaxime was 19.45%, for azithromycin and erythromycin was 23.61%, for trimethoprim/ sulfamethoxazole was 61.11%, for amoxicillin was 5.5%, and for clindamycin was 12.5%. With amoxicillin/clavulanate, ceftriaxone, imipenem, meropenem, teicoplanin, telithromycin, and vancomycin, we found susceptibility for 100% of the isolates. The most common resistant serotypes were 19F and 23F. CONCLUSIONS: The serotype distribution of S pneumoniae that causes pediatric AOM in Mexico is similar to that reported from developed countries. The current heptavalent pneumococcal conjugate vaccine covers 63.89% of AOM episodes in Mexican children. destruction after infections with Plasmodium falciparum or Plasmodium vivax. OBJECTIVE: Our goal was to investigate whether thrombomodulin levels can be used to detect the endothelial cell destruction after tropical or tertian malaria and whether thrombomodulin is related to the severity of tropical malaria. METHODS: This was a cross-sectional observational analytical study conducted in 5 hospitals in north Sulawesi, Indonesia, from June to September 2006, in patients aged 2 to 13 years with tropical or tertian malaria. Thrombomodulin levels were determined with an enzyme-linked immunosorbent assay using a thrombomodulin kit (Fujirebio Diagnostics, Inc, Malvern, PA). Data were analyzed by independent t test and Spearman rank correlation coefficient. RESULTS: For 30 patients with tropical malaria (thrombomodulin level: 0.060 -0.180 FU/mL) and 2 patients with tertian malaria (thrombomodulin level: 0.068 -0.075 FU/mL), there was a significant difference in t-test results between tropical and tertian malaria (P ϭ .044). For 11 patients with severe malaria (thrombomodulin level: 0.086 -0.162 FU/mL), there was also a very significant difference in t-test results for complicated and uncomplicated tropical malaria (P ϭ .009). The Spearman rank test showed significant positive correlation between thrombomodulin and parasitemia levels (r s ϭ 0.686; P ϭ .001). CONCLUSIONS: Thrombomodulin levels can be used to detect endothelial cell destruction in malaria; the thrombomodulin level in tropical malaria was found to be higher than that of tertian malaria. Thrombomodulin levels were very significantly different in complicated and uncomplicated tropical malaria and also correlated significantly with the degree of parasitemia. 42.3%-55.7%). Most children with PRG (71.7%) were between 6 months and 3 years old. Behavioral changes and signs of dehydration, weight loss, fever at Ն38°C, diarrhea, and vomiting were more prevalent with PRG (P Ͻ .01). In children with PRG, a higher incidence of moderate or severe gastroenteritis (P ϭ .013 and .021, respectively), hospitalization (P ϭ .011), and need for a clinical reevaluation (P ϭ .012) was observed, as was longer hospitalization (5.14 Ϯ 3.18 vs 3.69 Ϯ 2.25 days; P ϭ .039). CONCLUSIONS: PRG was responsible for nearly half the patients with AGE who visited HEUs or required hospitalization. Vaccination against rotavirus would help prevent this frequent and often severe disease.
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